Portfolio Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,092
Closed -$37K 141
2018
Q1
$37K Buy
1,092
+118
+12% +$4.06K 0.01% 80
2017
Q4
$33K Buy
974
+2
+0.2% +$68 ﹤0.01% 79
2017
Q3
$33K Sell
972
-6,848
-88% -$220K ﹤0.01% 80
2017
Q2
$249K Buy
7,820
+4
+0.1% +$126 0.03% 34
2017
Q1
$254K Buy
7,816
+3
+0% +$95 0.04% 26
2016
Q4
$241K Buy
7,813
+3
+0% +$92 0.03% 31
2016
Q3
$251K Hold
7,810
0.04% 29
2016
Q2
$261K Buy
+7,810
New +$249K 0.04% 27

Other funds holding PFE

Portfolio Solutions's PFE Position: Q2 2018 in Review

Portfolio Solutions sold out of Pfizer (PFE) in Q2 2018, closing a stake of 1,092 shares — an estimated $37K sold.

Portfolio Solutions first reported a position in PFE in Q2 2016 and held it in 8 quarters. The position peaked at $261K in Q2 2016. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Portfolio Solutions reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
  • Portfolio Solutions sold 1,092 Pfizer shares in Q2 2018, an estimated $37K.
  • Portfolio Solutions first reported a position in Pfizer in Q2 2016 and held it in 8 quarters.
  • Portfolio Solutions's Pfizer position peaked at $261K in Q2 2016.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.